- Home
- LVTX vs PLUT Comparison
LVTX vs PLUT Comparison
Compare LVTX & PLUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- PLUT
- Stock Information
- Founded
- LVTX 2016
- PLUT 2018
- Country
- LVTX Netherlands
- PLUT Hong Kong
- Employees
- LVTX N/A
- PLUT N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- PLUT
- Sector
- LVTX Health Care
- PLUT
- Exchange
- LVTX Nasdaq
- PLUT NYSE
- Market Cap
- LVTX 33.9M
- PLUT 34.1M
- IPO Year
- LVTX 2021
- PLUT 2025
- Fundamental
- Price
- LVTX $1.43
- PLUT $2.98
- Analyst Decision
- LVTX Hold
- PLUT
- Analyst Count
- LVTX 3
- PLUT 0
- Target Price
- LVTX $1.75
- PLUT N/A
- AVG Volume (30 Days)
- LVTX 30.6K
- PLUT 67.6K
- Earning Date
- LVTX 08-19-2025
- PLUT 01-01-0001
- Dividend Yield
- LVTX N/A
- PLUT N/A
- EPS Growth
- LVTX N/A
- PLUT N/A
- EPS
- LVTX N/A
- PLUT N/A
- Revenue
- LVTX $4,990,000.00
- PLUT $1,408,881.00
- Revenue This Year
- LVTX N/A
- PLUT N/A
- Revenue Next Year
- LVTX N/A
- PLUT N/A
- P/E Ratio
- LVTX N/A
- PLUT N/A
- Revenue Growth
- LVTX N/A
- PLUT 19.61
- 52 Week Low
- LVTX $0.85
- PLUT $2.04
- 52 Week High
- LVTX $2.21
- PLUT $4.22
- Technical
- Relative Strength Index (RSI)
- LVTX 58.31
- PLUT N/A
- Support Level
- LVTX $1.40
- PLUT N/A
- Resistance Level
- LVTX $1.67
- PLUT N/A
- Average True Range (ATR)
- LVTX 0.10
- PLUT 0.00
- MACD
- LVTX 0.00
- PLUT 0.00
- Stochastic Oscillator
- LVTX 33.33
- PLUT 0.00
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About PLUT PLUTUS FINANCIAL GROUP LIMITED
Plutus Financial Group Ltd provides financial services. The company has two reportable segments: securities related services and asset management services. The securities related services segment generated commission by offering securities dealing and brokerage services, securities underwriting and placing services, and other financing services. The asset management services segment generated asset management fee by providing asset management services and investment advisory services.